BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 14563078)

  • 1. Diminishing returns? The costs and benefits of improving health.
    Murphy K; Topel R
    Perspect Biol Med; 2003; 46(3 Suppl):S108-28. PubMed ID: 14563078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of aortic valve replacement in elderly patients: an economic analysis.
    Wu Y; Grunkemeier GL; Starr A
    J Thorac Cardiovasc Surg; 2007 Mar; 133(3):603-7. PubMed ID: 17320551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USA.
    Palmer AJ; Valentine WJ; Chen R; Mehin N; Gabriel S; Bregman B; Rodby RA
    Nephrol Dial Transplant; 2008 Apr; 23(4):1216-23. PubMed ID: 18359872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is medical research cost effective? Response to Murphy and Topel.
    Siegler M; Weisfeld A; Cronin D
    Perspect Biol Med; 2003; 46(3 Suppl):S129-37. PubMed ID: 14563079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Could a federal program to promote influenza vaccination among elders be cost-effective?
    Patel MS; Davis MM
    Prev Med; 2006 Mar; 42(3):240-6. PubMed ID: 16480761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The economic burden of lung cancer and the associated costs of treatment failure in the United States.
    Kutikova L; Bowman L; Chang S; Long SR; Obasaju C; Crown WH
    Lung Cancer; 2005 Nov; 50(2):143-54. PubMed ID: 16112249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in mortality differentials and life expectancy for male social security-covered workers, by socioeconomic status.
    Waldron H
    Soc Secur Bull; 2007; 67(3):1-28. PubMed ID: 18605216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic costs of diabetes in the U.S. In 2007.
    American Diabetes Association
    Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective cost-effectiveness analyses for polio vaccination in the United States.
    Thompson KM; Tebbens RJ
    Risk Anal; 2006 Dec; 26(6):1423-40. PubMed ID: 17184390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventive health screenings and health consultations in primary care increase life expectancy without increasing costs.
    Rasmussen SR; Thomsen JL; Kilsmark J; Hvenegaard A; Engberg M; Lauritzen T; Søgaard J
    Scand J Public Health; 2007; 35(4):365-72. PubMed ID: 17786799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aging diseases--do they prevent preventive health care from saving costs?
    Gandjour A
    Health Econ; 2009 Mar; 18(3):355-62. PubMed ID: 18833543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost effectiveness of community-based physical activity interventions.
    Roux L; Pratt M; Tengs TO; Yore MM; Yanagawa TL; Van Den Bos J; Rutt C; Brownson RC; Powell KE; Heath G; Kohl HW; Teutsch S; Cawley J; Lee IM; West L; Buchner DM
    Am J Prev Med; 2008 Dec; 35(6):578-88. PubMed ID: 19000846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic evaluation of the US Environmental Protection Agency's SunWise program: sun protection education for young children.
    Kyle JW; Hammitt JK; Lim HW; Geller AC; Hall-Jordan LH; Maibach EW; De Fabo EC; Wagner MC
    Pediatrics; 2008 May; 121(5):e1074-84. PubMed ID: 18450850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States.
    Rein DB; Wittenborn JS; Lee PP; Wirth KE; Sorensen SW; Hoerger TJ; Saaddine JB
    Ophthalmology; 2009 May; 116(5):823-32. PubMed ID: 19285730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of prevention on reducing the burden of cardiovascular disease.
    Kahn R; Robertson RM; Smith R; Eddy D
    Circulation; 2008 Jul; 118(5):576-85. PubMed ID: 18606915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Costs and benefits of combining probation and substance abuse treatment.
    Alemi F; Taxman F; Baghi H; Vang J; Thanner M; Doyon V
    J Ment Health Policy Econ; 2006 Jun; 9(2):57-70. PubMed ID: 17007484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The economics of routine childhood hepatitis A immunization in the United States: the impact of herd immunity.
    Armstrong GL; Billah K; Rein DB; Hicks KA; Wirth KE; Bell BP
    Pediatrics; 2007 Jan; 119(1):e22-9. PubMed ID: 17200247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic cost of Guillain-Barré syndrome in the United States.
    Frenzen PD
    Neurology; 2008 Jul; 71(1):21-7. PubMed ID: 18591502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing the use of arteriovenous fistula in hemodialysis: economic benefits and economic barriers.
    Schon D; Blume SW; Niebauer K; Hollenbeak CS; de Lissovoy G
    Clin J Am Soc Nephrol; 2007 Mar; 2(2):268-76. PubMed ID: 17699424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.